How To Use doxorubicin In A Sentence
- Ms. Manzoor's research suggests that ThermoDox's high velocity release of doxorubicin intravascularly may have an anti-tumor vascular effect in the treatment of certain cancer tumors. The Earth Times Online Newspaper
- Our patient did not respond to cyclophosphamide, doxorubicin, vincristine, and prednisone combination therapy as has been the experience with all other patients with PEL.
- Cancer drugs used for primary bone cancer include methotrexate, doxorubicin, and cisplatin.
- Due to the bulky nature of the disease, all the patients had received a course of chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine, and they were scheduled for MRT.
- Leukemia lines resistant to either doxorubicin, vincristine, methotrexate, or hydroxyurea were tested.
- The patient was treated with adjuvant chemotherapy consisting of doxorubicin and cyclophosphamide for 4 cycles; she handled the treatment well.
- Adjuvant therapy, multidrug chemotherapy was carried out with methotrexate, cyclophosphamide, doxorubicin, vincristine, and prednisone.
- It has been reported that doxorubicin can be concentrated to such an extent within liposomes that gelation takes place in the presence of the divalent sulfate counterion.
- The patient was treated per the hyper-CVAD protocol (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) with intrathecal prophylaxis and achieved a complete remission.
- In any case, what he found was that treating two different leukemia and lymphoma cell lines with ascorbate at those concentrations before treating them with chemotherapeutic agents, including mechanistically dissimilar agents such as doxorubicin, which intercalates with DNA and causes DNA breaks; methotrexate, which inhibits folate metabolism; cisplatin, which crosslinks DNA; vincristine, which interferes with microtubule function; and imatinib mesylate (better known by its trade name of Gleevec), a selective inhibitor of the activity of a protein called bcr-abl, which is the oncogene that plays a central role in the development of chronic myelogenous leukemia (CML). Adrian Monck